[go: up one dir, main page]

JPS6021599B2 - 2-methacryloxyethylphosphorylcholine - Google Patents

2-methacryloxyethylphosphorylcholine

Info

Publication number
JPS6021599B2
JPS6021599B2 JP13008177A JP13008177A JPS6021599B2 JP S6021599 B2 JPS6021599 B2 JP S6021599B2 JP 13008177 A JP13008177 A JP 13008177A JP 13008177 A JP13008177 A JP 13008177A JP S6021599 B2 JPS6021599 B2 JP S6021599B2
Authority
JP
Japan
Prior art keywords
methacryloxyethylphosphorylcholine
add
hours
monomer
methacryloxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13008177A
Other languages
Japanese (ja)
Other versions
JPS5463025A (en
Inventor
淳一 山内
英一 増原
宣男 中林
義則 門磨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Priority to JP13008177A priority Critical patent/JPS6021599B2/en
Publication of JPS5463025A publication Critical patent/JPS5463025A/en
Publication of JPS6021599B2 publication Critical patent/JPS6021599B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Graft Or Block Polymers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Description

【発明の詳細な説明】 本発明は の化学式で表わされる、新規な化合物である2−メタク
リルオキシエチルホスホリルコリンおよびその製造方法
に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel compound 2-methacryloxyethylphosphorylcholine represented by the chemical formula and a method for producing the same.

本発明の2ーメタクリルオキシェチルホスホリルコリン
は重合単量体として用いられ、該単量体とメチルメタク
リレートなどの他の単量体との共重合体および該単量体
をポリメチルメタクリレートなどの他の重合体へグラフ
ト重合することにより得られた共重合体は生体組織に対
して優れた親和性を有するので、人工器官の材料として
有用である。近年、合成高分子材料が人工臓器などに広
く応用されるようになり、生体組織との機能的なかかわ
り合いのある合成高分子材料が求められるようになって
きた。
The 2-methacryloxyethylphosphorylcholine of the present invention is used as a polymerization monomer, and the monomer is used as a copolymer with other monomers such as methyl methacrylate, and the monomer is used as a copolymer with other monomers such as polymethyl methacrylate. The copolymer obtained by graft polymerization to the polymer has excellent affinity for living tissues and is therefore useful as a material for artificial organs. In recent years, synthetic polymer materials have come to be widely applied to artificial organs, etc., and there has been a demand for synthetic polymer materials that are functionally related to living tissues.

本発明者等は生体組織と高分子材料の界面において好ま
しい相互作用が期待されるような高分子材料として、生
体膜の主要な構成成分で細胞の膜様構造に特異的に存在
しているリン脂質に類似した構造を有する高分子材料を
得るべく鋭意研究した結果、レシチンに類似したコリン
基を有する2ーメタクリルオキシェチルホスホリルコリ
ン単量体を合成し、該単量体を単独で、あるいは他の単
量体(または重合体)と共に重合させることにより得ら
れた重合体は生体組織に対して優れた適合性を有するこ
とを見出し、本発明に到達した。本発明の2ーメタクリ
ルオキシェチルホスホリルコリンは新規化合物であるが
、次の方法により製造することができる。
The present inventors have proposed a polymeric material that is expected to have a favorable interaction at the interface between biological tissues and polymeric materials. As a result of intensive research to obtain a polymeric material with a structure similar to lipids, we synthesized a 2-methacryloxyethylphosphorylcholine monomer having a choline group similar to lecithin. It has been discovered that a polymer obtained by polymerization with a monomer (or polymer) of 1 has excellent compatibility with living tissue, and the present invention has been achieved based on this finding. The 2-methacryloxyethylphosphorylcholine of the present invention is a new compound and can be produced by the following method.

2−ヒドロキシエチルメタクリレートと2ープロムエチ
ルホスホリルジクロラィドを3級塩基の存在下、不活性
溶媒中で反応して中間体である2ーメタクリルオキシェ
チル2ーブロムエチルハイドロジエンホスフエイトを合
成し、該化合物をトリメチルアミンと反応させることに
より得られる。
2-Hydroxyethyl methacrylate and 2-promoethylphosphoryl dichloride are reacted in an inert solvent in the presence of a tertiary base to synthesize the intermediate 2-methacryloxyethyl 2-bromoethylhydrodiene phosphate. It can be obtained by reacting the compound with trimethylamine.

本発明において中間体である2−メタクリルオキシエチ
ル 2ープロムエチルハイドロジエンホスフアィトを合
成するにあたって用いられる不活性溶媒としては反応に
関与しないものであれば何でもよく、例えばエーテル、
クロロホルム、ベンゼン、テトラヒドロフラン等が挙げ
られる。
In the present invention, any inert solvent used in synthesizing the intermediate 2-methacryloxyethyl 2-promoethylhydrodiene phosphite may be used as long as it does not participate in the reaction, such as ether,
Examples include chloroform, benzene, and tetrahydrofuran.

また3級塩基としては通常脱ハロゲン化水素剤として使
用されるピリジン、キノリン、トリェチルアミン等を用
いることができる。反応条件としては反応性が非常に高
いために低温(一20o〜室温)で反応させることが好
ましく、さらに2ーブロムェチルホスホリルジクロライ
Nこ対して2−ヒドロキシェチルメタクリレートを徐々
に滴下して反応させることが望ましい。また、2ーメタ
クリルオキシエチル 2ーブロムエチルハイドロジエン
ホスフエートから2ーメタクリルオキシエチルホスホリ
ルコリンへの合成は前者にトリメチルアミンのメタノー
ル溶液を加えて室温にて反応させ、次いで炭酸銀を加え
て脱臭化銀処理することにより行われる。本発明の2ー
メタクリルオキシェチルホスホリンコリン単量体は通常
のメタクリル酸ェステル単豊体と同様、ラジカル重合開
始剤の作用により単独であるいは他の単量体あるいは他
の重合体と共に重合することが可能である。
Further, as the tertiary base, pyridine, quinoline, triethylamine, etc., which are usually used as dehydrohalogenation agents, can be used. As for the reaction conditions, it is preferable to carry out the reaction at a low temperature (-20°C to room temperature) because the reactivity is very high, and further, 2-hydroxyethyl methacrylate is gradually added dropwise to the 2-bromoethylphosphoryl dichloride N. It is desirable to react with In addition, to synthesize 2-methacryloxyethyl 2-bromoethylhydrodiene phosphate to 2-methacryloxyethylphosphorylcholine, a methanol solution of trimethylamine is added to the former to react at room temperature, and then silver carbonate is added to desilver bromide. This is done by processing. The 2-methacryloxyethylphosphorine choline monomer of the present invention can be polymerized alone or together with other monomers or other polymers by the action of a radical polymerization initiator, similar to ordinary methacrylic acid ester monomers. Is possible.

得られた2−メタクリルオキシエチルホスホリルコリン
とメチルメタクリレートとの共重合体、また、該単量体
とポリメチルメタクリレートとのグラフト共重合体は生
体組織との適合性の尺度となる溶血性式験の結果から優
れた生体との適合性を有することが認められた。かかる
共重合体はカテーテル、人工皮膚、コンタクトレンズ、
ィンプラント材料として有用である。さらに、本発明の
2−メタクリルオキシェチルホスホリルコリンを塩化ピ
ニル、スチレン、アクリル酸ヱステル、ヒドロキシェチ
ルメタクリレート等の単量体を共重合することにより得
られる共重合体、またはナイロン、ポリウレタンなど他
の重合体とのグラフト重合により得られる共重合体も生
体適合性に優れ、同様に人工器官材料として有用である
。以下実施例により本発明をさらに具体的に説明するが
、本発明は実施例に限定されるものではない。
The resulting copolymer of 2-methacryloxyethylphosphorylcholine and methyl methacrylate, as well as the graft copolymer of this monomer and polymethyl methacrylate, has a hemolytic index that is a measure of compatibility with living tissue. The results showed that it had excellent compatibility with living organisms. Such copolymers are used in catheters, artificial skin, contact lenses,
Useful as an implant material. Furthermore, copolymers obtained by copolymerizing the 2-methacryloxyethylphosphorylcholine of the present invention with monomers such as pinyl chloride, styrene, ester acrylate, and hydroxyethyl methacrylate, or other copolymers such as nylon and polyurethane, may also be used. Copolymers obtained by graft polymerization with polymers also have excellent biocompatibility and are similarly useful as artificial organ materials. EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited to the Examples.

実施例 1 2−メタクリルオキシエチルホスホリルコリンの合成‘
112ーブロムエチルホスホリルジクロライドの合成温
度計、滴下ロート、塩化カルシウム管のついた冷却器を
フラスコに取りつけ、脱水乾燥した四塩化炭素100w
‘と蒸留したオキシ塩化リン210夕をフラスコ中に加
え、水浴中で20℃でエチレンブロムヒドリン124夕
を適下する。
Example 1 Synthesis of 2-methacryloxyethylphosphorylcholine'
Synthesis of 112-bromoethylphosphoryl dichloride Attach a thermometer, a dropping funnel, and a condenser with a calcium chloride tube to the flask, and add 100 w of dehydrated and dried carbon tetrachloride.
210 parts of phosphorus oxychloride distilled from '' were added to the flask, and 124 parts of ethylene bromohydrin was added at 20°C in a water bath.

滴下終了後一夜放置したのち、徐々に加熱して30分間
還流させてから蒸留して精製し、2−プロムェチルホス
ホリルジクロラィド146夕を得た(収率61%)。無
色液体b.p.m側日難5.8〜87.80○。(2’
2ーメタクリルオキシエチル 2ープロムエチルハイド
ロジヱンホスフエート(ロ)の合成 3つ口フラスコに蝿洋器、温度計および塩化カルシウム
管を付けた滴下ロートを取りつけ、175の‘の脱水ク
ロロホルムに溶解させ2−フロムヱチルホスホリルジク
ロライド(1)116.7夕をフラスコに加える。
After the dropwise addition was completed, the mixture was allowed to stand overnight, and then gradually heated and refluxed for 30 minutes, followed by distillation and purification to obtain 2-promethylphosphoryl dichloride 146 (yield: 61%). colorless liquid b. p. m side sun damage 5.8~87.80○. (2'
Synthesis of 2-methacryloxyethyl 2-promoethylhydrodiene phosphate (b) A three-necked flask was equipped with a dropping funnel equipped with a thermometer, a thermometer, and a calcium chloride tube, and added to 175' of dehydrated chloroform. Dissolve and add 116.7 hours of 2-furomethylphosphoryl dichloride (1) to the flask.

175泌の脱水クロロホルムに2−ヒドロキシエチルメ
タクリレート59.82および脱水トリェチルアミン5
42を溶解させた溶液を滴下ロ−トに加え、一20qo
に氷袷縄梓下徐々に滴下する。
175 secretions of dehydrated chloroform, 2-hydroxyethyl methacrylate 59.82 and dehydrated triethylamine 5
Add the solution in which 42 was dissolved into the dropping funnel, and add 120 qo
Gradually dripping onto the ice rope Azusa.

滴下終了後0℃でさらに1時間反応させてから、ロータ
リーェバポレーターで濃縮する。冷却すると徐々にトリ
ェチルアミソ塩酸塩が析出し、析出固体を炉別する。反
液にトリェチルアミン4.4夕および水13.5夕を0
℃で徐々に燈拝しながら滴下して中和し、1時間放置し
てからさらに析出したトリェチルアミン塩酸塩を炉刻す
る。炉液にハイドロキノンを少量加えてから酢酸バリウ
ム64.5夕を水120の‘に溶解させた溶液を加えて
水冷下1時間よく振とうする。水届を取り出し、塩酸を
加えIN塩酸溶液にしてからクロロホルム100の【を
加えてよく振とうし有機層を取る。クロロホルムによる
抽出を3回繰り返しクロロホルム層に苔硝を加えて脱水
後、ロータリーェバボレーターにより濃縮すると95夕
の残澄が得られる。これを四塩化炭素で再結晶を2回行
うと無色小葵状結晶として聡夕の2ーメタクリルオキシ
ェチル 2−ブロムエチルハイドロジエンホスフヱート
(0)が得られた(収率26%)。mP.456〜46
.030。
After the completion of the dropwise addition, the reaction was continued for an additional hour at 0°C, and then concentrated using a rotary evaporator. When cooled, triethylamiso hydrochloride gradually precipitates, and the precipitated solid is separated by furnace. Add 4.4 hours of triethylamine and 13.5 hours of water to the reaction solution.
The mixture was gradually added dropwise to neutralize it at ℃, and after being allowed to stand for 1 hour, the precipitated triethylamine hydrochloride was chopped in an oven. Add a small amount of hydroquinone to the furnace solution, then add a solution of 64.5 parts barium acetate dissolved in 120 parts water, and shake well for 1 hour under water cooling. Take out the water bottle, add hydrochloric acid to make an IN hydrochloric acid solution, add 100% of chloroform, shake well, and remove the organic layer. Extraction with chloroform is repeated three times, moss salt is added to the chloroform layer for dehydration, and the mixture is concentrated using a rotary evaporator to obtain a 95% residue. When this was recrystallized twice with carbon tetrachloride, Satoshi's 2-methacryloxyethyl 2-bromoethylhydrodiene phosphate (0) was obtained as colorless hollyhock-like crystals (yield 26%). ). mP. 456-46
.. 030.

元素分析結果 ○係) 日協 P係)分 析値
30.30 4.46 9.77計算 値
30.55 4.59 9.96(C8日,
406PBrとして)IR(KBr):1730(C:
0)、I64O(C=C)、129瓜均一1(P=0)
NMR 6脚(CDCl3) 【a’5.63【b16.17、(c’1.97、【d
14.13〜4.83、【e}3.52、{fill.
46‘31 2−メタクリルオキシエチルホスホリルコ
リン(m)の合成 脱水メタノール80肌にドライアイスで液化したトリメ
チルアミン10の【を混合し、2−メタクリルオキシエ
チル 2−ブロムエチルハイドロジェンホスフェート(
0)6.3夕を加えて溶解させる。
Elemental analysis results Section ○) Section P, Japan Association) Analysis value
30.30 4.46 9.77 Calculated value
30.55 4.59 9.96 (C8th,
406PBr) IR (KBr): 1730 (C:
0), I64O (C=C), 129 melon uniform 1 (P=0)
NMR hexapod (CDCl3) [a'5.63[b16.17, (c'1.97, [d
14.13-4.83, [e}3.52, {fill.
46'31 Synthesis of 2-methacryloxyethylphosphorylcholine (m) Mix 80 parts of dehydrated methanol with 10 parts of trimethylamine liquefied with dry ice, and prepare 2-methacryloxyethyl 2-bromoethyl hydrogen phosphate (
0) Add and dissolve 6.3 hours.

15〜2ぴ0にて2日間反応させてからロータリーェバ
ポレータ−で濃縮させること薄桃色の粕調な液体が得ら
れる。
After reacting for 2 days at 15 to 20°C, the mixture was concentrated using a rotary evaporator to obtain a pale pink, dregs-like liquid.

この液体を50の‘のメタノールに溶解させてから2.
5夕の炭酸線を加えて室温で2時間燈拝しながら反応し
、炉過した後炉液をロータリーェバボレーターで濃縮し
て粘調状な液体を得る。この液体をシリカゲルカラムク
ロマト処理(クロロホルム/メタノール/水=65:2
5:4で溶出)して結晶状の2ーメタクリルオキシエチ
ルホスホリルコリン(m)1.8夕を得た(収率28%
)。mp:1斑一141℃。元素分析結果 0■ 日■
N協P 隊)分析値 42.17 7.72 4.4
7 9.89計 算値 41.10 7.53 4.5
8 9.88(C,.日2407NPとして)IR(K
Br)9斑(N十(CH3)3)、1240(Pニ0)
、16紙(CニC)、1715(Cニ0)NMR 6脚
(CDCl3)【a)5.50(b}6.0入【c11
.81、【d)4.08〜4.34、【e’3.97、
{f13.26実施例 2メチルメタクリレート(MM
A)と2−メタクリルオキシエチルホスホリルコリン(
MPC)を表1に示すような仕込比で共重合させ、得ら
れた共重合体の溶血性を調べた。
Dissolve this liquid in 50' methanol and then 2.
Add carbon dioxide for 5 nights, react at room temperature for 2 hours, and after filtering, concentrate the furnace liquid using a rotary evaporator to obtain a viscous liquid. This liquid was treated with silica gel column chromatography (chloroform/methanol/water = 65:2
5:4) to obtain 1.8 ml of crystalline 2-methacryloxyethylphosphorylcholine (yield: 28%).
). mp: 1 spot 141℃. Elemental analysis results 0■ Day■
N-coop P squad) analysis value 42.17 7.72 4.4
7 9.89 Calculated value 41.10 7.53 4.5
8 9.88 (as C,.day 2407NP) IR (K
Br) 9 spots (N 10 (CH3) 3), 1240 (P ni 0)
, 16 paper (CniC), 1715 (Cni0) NMR 6 legs (CDCl3) [a) 5.50 (b} 6.0 pieces [c11
.. 81, [d) 4.08-4.34, [e'3.97,
{f13.26 Example 2 Methyl methacrylate (MM
A) and 2-methacryloxyethylphosphorylcholine (
MPC) was copolymerized at the charging ratio shown in Table 1, and the hemolytic properties of the obtained copolymers were examined.

重合条件としては溶媒としてメタノール:ジメチルホル
ムアミド=1:1を用い、MBN(0.9モル%/モノ
マー)を開始剤として6ぴ0で5時間重合を行った。重
合後反応液をメタノールーェーテル系で再沈澱を行うと
白色状のポリマーが得られた。これらのポリマーをクロ
ロホルムノメタノール混合溶媒からキャスト法でフィル
ムを作成し、溶血試験に用いた。溶血試験は次のように
して行った。3日間生理食塩水に浸潰した直径14側の
円状フィルムをガラス試験管の底に置き、その上からラ
ットの赤血球を約0.25%の濃度に分散させた生理食
塩水を静かに注いだ後37q0の恒温槽中に2凪時間静
遣した。
The polymerization conditions were as follows: methanol:dimethylformamide=1:1 was used as a solvent, MBN (0.9 mol %/monomer) was used as an initiator, and polymerization was carried out at 6 pm for 5 hours. After the polymerization, the reaction solution was reprecipitated using a methanol-ether system to obtain a white polymer. Films of these polymers were made by casting from a mixed solvent of chloroformomethanol and used in hemolysis tests. The hemolysis test was conducted as follows. A circular film with a diameter of 14 sides soaked in physiological saline for 3 days was placed on the bottom of a glass test tube, and physiological saline in which rat red blood cells were dispersed at a concentration of approximately 0.25% was gently poured over it. After that, it was placed in a constant temperature bath at 37q0 for 2 hours.

分散した赤血球はポリマー表面上に沈澱するので遠心分
離を行って上澄み液を分離し、UVスペクトルを用いて
血球が破壊して溶血したヘモグロビンを測定することに
より溶血率を求めた。結果を表1に示した。表 1 MMA−MPC共重合体においてMPCを共重合成分と
することによりPMMAよりもかなり溶皿率が低下し、
生体適合性を著しく向上させる効果のあることが認めら
れた。
Since the dispersed red blood cells precipitated on the polymer surface, the supernatant was separated by centrifugation, and the hemolysis rate was determined by measuring hemoglobin produced by destruction of the blood cells and hemolysis using UV spectroscopy. The results are shown in Table 1. Table 1 By using MPC as a copolymerization component in the MMA-MPC copolymer, the melt plate rate is considerably lower than that of PMMA,
It was recognized that it has the effect of significantly improving biocompatibility.

実施例 3 ポリメチルメタクリレート(PMMA)およびポリスチ
レン(PSt)に対してMPCのグラフト共重合を次の
条件で行い、グラフト共重合体の溶血性を調べた。
Example 3 Graft copolymerization of MPC to polymethyl methacrylate (PMMA) and polystyrene (PSt) was carried out under the following conditions, and the hemolytic property of the graft copolymer was investigated.

過酸化ペンゾィルを含むメタノール溶液(13夕/夕)
にPMMAまたはPStのポリマーフィルムを5び0で
1凪時間浸潰した後、フィルムを取り出し60qoで1
.5時間熱処理を行ってから、M円Cのメタノール溶液
(混合比2:lwt)に浸潰して60qoにて4餌時間
加熱してグラフト共重合を行った。ついで、得られたフ
ィルムを充分水で抽出してMPCのホモポリマーを除い
てから溶血試験を行った。その結果を第2表に示す。第
2表 PMMAおよびPStともにMPCをグラフト共重合す
ることにより溶血率の低下が認められた。
Methanol solution containing penzoyl peroxide (13th evening/evening)
After soaking a polymer film of PMMA or PSt at 5 and 0 for 1 hour, the film was taken out and soaked at 60 qo for 1 hour.
.. After heat treatment for 5 hours, the mixture was soaked in a methanol solution of M-C (mixing ratio 2:1wt) and heated at 60 qo for 4 hours to perform graft copolymerization. Next, the obtained film was sufficiently extracted with water to remove the MPC homopolymer, and then a hemolysis test was conducted. The results are shown in Table 2. Table 2 A decrease in the hemolysis rate was observed by graft copolymerizing MPC with both PMMA and PSt.

Claims (1)

【特許請求の範囲】[Claims] 1 1 2−メタクリルオキシエチルホスホリルコリン
2 2−ヒドロキシエチルメタクリレートと2−ブロム
エチルホスホリルジクロライドを3級塩基の存在下、不
活性溶媒中で反応させ、得られる2−メタクリルオキシ
エチル2′−ブロムエチルハイドロジエンホスフエイト
をトリメチルアミンと反応させることを特徴とする2−
メタクリルオキシエチルホスホリルコリンの製造方法。
1 1 2-methacryloxyethylphosphorylcholine 2 2-Methacryloxyethyl 2'-bromoethylhydro is obtained by reacting 2-hydroxyethyl methacrylate and 2-bromoethylphosphoryl dichloride in an inert solvent in the presence of a tertiary base. 2- characterized in that diene phosphate is reacted with trimethylamine.
Method for producing methacryloxyethylphosphorylcholine.
JP13008177A 1977-10-28 1977-10-28 2-methacryloxyethylphosphorylcholine Expired JPS6021599B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13008177A JPS6021599B2 (en) 1977-10-28 1977-10-28 2-methacryloxyethylphosphorylcholine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13008177A JPS6021599B2 (en) 1977-10-28 1977-10-28 2-methacryloxyethylphosphorylcholine

Publications (2)

Publication Number Publication Date
JPS5463025A JPS5463025A (en) 1979-05-21
JPS6021599B2 true JPS6021599B2 (en) 1985-05-28

Family

ID=15025522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13008177A Expired JPS6021599B2 (en) 1977-10-28 1977-10-28 2-methacryloxyethylphosphorylcholine

Country Status (1)

Country Link
JP (1) JPS6021599B2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010185A1 (en) * 1980-03-17 1981-09-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen POLYMERIZABLE PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PRODUCTION OF POLYMER PHOSPHOLIPIDS
JPS60119955A (en) * 1983-12-02 1985-06-27 鶴田 禎二 Synthetic polymer body for living body material
GB9118597D0 (en) * 1991-08-30 1991-10-16 Biocompatibles Ltd Polymer treatments
JP2832119B2 (en) * 1992-11-17 1998-12-02 ポーラ化成工業株式会社 Cosmetics
GB9226791D0 (en) 1992-12-23 1993-02-17 Biocompatibles Ltd New materials
EP0767212B1 (en) 1995-04-03 2001-07-18 Nof Corporation Process for producing an aqueous solution of phosphorylcholine group bearing polymer and aqueous solution of phosphorylcholine group bearing polymer
US6258371B1 (en) 1998-04-03 2001-07-10 Medtronic Inc Method for making biocompatible medical article
DE60041418D1 (en) 1999-11-09 2009-03-05 Nof Corp COMPOSITION FOR HYDROGEL, HYDROGEL AND ITS USE
JP2001288209A (en) * 2000-04-10 2001-10-16 Nof Corp Method for producing polymer containing phosphorylcholine-like group
JP4727938B2 (en) * 2004-02-24 2011-07-20 泰彦 岩崎 Production method and use of polyphosphoric acid having living radical polymerization initiating group
JP4727941B2 (en) * 2004-03-12 2011-07-20 泰彦 岩崎 Production method and use of biodegradable polymer
JP2010527402A (en) * 2007-05-14 2010-08-12 タイコ ヘルスケア グループ リミテッド パートナーシップ Furanone copolymer
US7923439B2 (en) * 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
EP2360193B1 (en) * 2008-11-21 2016-02-10 Kyocera Medical Corporation Graft polymerization method and product obtained thereby
EP2422825A4 (en) * 2009-04-24 2014-07-02 Next 21 K K MEDICAL RESIN-BASED PRODUCT AND RESPIRATORY SUPPORT TUBE
WO2011125618A1 (en) 2010-03-31 2011-10-13 旭化成クラレメディカル株式会社 Substrate for ligand immobilization and method for producing same
JP6150071B2 (en) 2011-09-16 2017-06-21 日産化学工業株式会社 Organosilicon compound and silane coupling agent containing the same
KR101797275B1 (en) 2012-03-02 2017-11-13 니치유 가부시키가이샤 Contact lens care preparation and packaging solution
CA2927423A1 (en) 2013-11-28 2015-06-04 Toray Industries, Inc. Anti-thrombotic material
JPWO2023276858A1 (en) 2021-06-29 2023-01-05

Also Published As

Publication number Publication date
JPS5463025A (en) 1979-05-21

Similar Documents

Publication Publication Date Title
JPS6021599B2 (en) 2-methacryloxyethylphosphorylcholine
US4379864A (en) Polymeric compositions and hydrogels formed therefrom
US4267295A (en) Polymeric compositions and hydrogels formed therefrom
JPS5828878B2 (en) Cyclic pyrophosphate derivative
US4781921A (en) Hydrogels of quadrol methacrylate polymers
US4889530A (en) Wound dressing containing acrylate or methacrylate hydrogel polymer
JPS59206392A (en) N-alkenoyltrialkylsilylaminate and biomedicinal device manufactured therefrom
JPH09504561A (en) Polymer surface coating material
KR100487016B1 (en) Modified polymers containing poly (2-hydroxyethyl(meth) acrylate) segment in the molecule
JPH08104664A (en) Novel (meth) acrylate monomer and denture base composition made therefrom
US4543371A (en) Polymeric compositions and hydrogels formed therefrom
EP0556216A1 (en) Phosphoric acid esters and their use in the preparation of biocompatible surfaces.
DE69233378T2 (en) Polymeric surface coating compositions
EP4053164A1 (en) Manufacture of photo-crosslinkable biodegradable tissue adhesive using copolymer
WO1997008177A1 (en) Fumaric acid derivative and polymer thereof
JPH03503182A (en) polymerizable composition
JP3993657B2 (en) Soluble cellulose derivative and production method
JPS60179408A (en) Compound having phospholipid-like structure and its polymer and production thereof
JP2004331637A (en) Bifunctional cross-linking agent monomer, method for producing the same and cross-linked polymer
US5274048A (en) Use of glycidyl phosphonates as crosslinkers in the preparation of hydrogels
US5068298A (en) Alkenyl-phosphonic and -phosphinic esters, process for their preparation, their use and hydrogels prepared using them
Ito et al. Silicon-containing block copolymer membranes
JP3692594B2 (en) Prepolymers and polyurethanes having phospholipid-like structures
US5453530A (en) S-(ω-hydroxyalkyl) esters of thioacrylic and thiomethacrylic acids
JPH07268038A (en) Copolymer with phosphorylcholine group or its derivative group, its production, and antithrombotic material